Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HEART FAILURE
Volume 19, Issue 11, Pages 1534-1541
Publisher
Wiley
Online
2017-04-10
DOI
10.1002/ejhf.826
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gene therapy for the treatment of heart failure: promise postponed
- (2016) Jean-Sebastien Hulot et al. EUROPEAN HEART JOURNAL
- Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial
- (2016) Barry Greenberg et al. LANCET
- Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure
- (2015) B Greenberg et al. GENE THERAPY
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
- (2015) Roberto M. Lang et al. European Heart Journal-Cardiovascular Imaging
- Impact of Inodilator Drugs on Echocardiographic Assessments of Left Ventricular Filling Pressure in Patients With Decompensated End-Stage Heart Failure*
- (2014) Joe-Elie Salem et al. CRITICAL CARE MEDICINE
- Biosafety of Recombinant Adeno-associated Virus Vectors
- (2014) David Dismuke et al. CURRENT GENE THERAPY
- Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart Failure
- (2013) Krisztina Zsebo et al. CIRCULATION RESEARCH
- EURObservationalResearch Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)
- (2013) Aldo P. Maggioni et al. EUROPEAN JOURNAL OF HEART FAILURE
- Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys
- (2013) F. Mingozzi et al. Science Translational Medicine
- Concomitant Intravenous Nitroglycerin With Intracoronary Delivery of AAV1.SERCA2a Enhances Gene Transfer in Porcine Hearts
- (2012) Ioannis Karakikes et al. MOLECULAR THERAPY
- Altered sarcoplasmic reticulum calcium cycling—targets for heart failure therapy
- (2012) Changwon Kho et al. Nature Reviews Cardiology
- Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID)
- (2011) Mariell Jessup et al. CIRCULATION
- Reversal of Cardiac Dysfunction After Long-Term Expression of SERCA2a by Gene Transfer in a Pre-Clinical Model of Heart Failure
- (2008) Yoshiaki Kawase et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Assessment of cardiac volumes by multidetector computed tomography
- (2008) Fay Y. Lin et al. Journal of Cardiovascular Computed Tomography
- Calcium Cycling and Signaling in Cardiac Myocytes
- (2007) Donald M. Bers Annual Review of Physiology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now